Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriers-Reference-Cited by-同舟云学术

Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriers

Published:2013-12-19 Issue:1 Volume:29 Page:173-178
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Mena Álvaro¹,Pedreira José D¹,Castro Ángeles¹,López Soledad¹,Vázquez Pilar¹,Poveda Eva¹

Affiliation:

1. Grupo de Virología Clínica, Instituto de Investigación Biomédica (INIBIC); Complejo Hospitalario Universitario de A Coruña (CHUAC), Sergas; La Coruña Spain

Funder

Fondo de Investigación Sanitaria

Fundación Profesor Novoa Santos, A Coruña

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.12432/fullpdf

Reference37 articles.

1. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures;Lavanchy;J. Viral Hepat.,2004

2. Hepatitis B virus. The major etiology of hepatocellular carcinoma;Beasley;Cancer,1988

3. Hepatitis B: epidemiology and natural history;Tran;Clin. Liver Dis.,2004

4. Nonalcoholic fatty liver disease: from steatosis to cirrhosis;Farrell;Hepatology,2006

5. A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases;Hirsch;Cancer Cell,2010

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of first-line nucleot(s)ide analogues on lipid profiles in patients with chronic hepatitis B: a network meta-analysis;European Journal of Clinical Pharmacology;2024-01-10

2. Chronic hepatitis B infection and diabetes mellitus: a double liver trouble?;Minerva Medica;2023-11

3. Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks;Alimentary Pharmacology & Therapeutics;2023-10-31

4. Dyslipidemia and impaired liver function biomarkers in patients with hepatitis B liver cirrhosis;Journal of Taibah University Medical Sciences;2023-08

5. Chronic-binge ethanol feeding aggravates systemic dyslipidemia in Ldlr-/- mice, thereby accelerating hepatic fibrosis;Frontiers in Endocrinology;2023-07-25